Abiopharma

Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants

New Form 144 - FULLER H B CO Filed: 2025-08-08 AccNo: 0001921094-25-000913 Size: 4 KB

New Form 10-Q - X4 Pharmaceuticals, Inc Filed: 2025-08-08 AccNo: 0001628280-25-039327 Size: 8 MB

New Form 10-Q - CUMBERLAND PHARMACEUTICALS INC Filed: 2025-08-08 AccNo: 0001628280-25-039326 Size: 4 MB

New Form 144 - AbbVie Inc. Filed: 2025-08-08 AccNo: 0001415889-25-021352 Size: 9 KB

New Form S-1 - SeaStar Medical Holding Corp Filed: 2025-08-08 AccNo: 0001213900-25-073745 Size: 13 MB

Ashland board authorizes quarterly dividend

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

New Form 10-Q - Actinium Pharmaceuticals, Inc. Filed: 2025-08-08 AccNo: 0001213900-25-073743 Size: 4 MB

New Form 8-K for Quantum-Si Incorporated

Puma Biotechnology, Inc. - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

New Form 3 - CATALYST PHARMACEUTICALS, INC. Filed: 2025-08-08 AccNo: 0001161697-25-000221 Size: 5 KB

New Form 4 - Royalty Pharma plc Filed: 2025-08-08 AccNo: 0001802768-25-000105 Size: 19 KB

CV Sciences, Inc. To Announce Second Quarter 2025 Results On August 13, 2025

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)